Prenetics Global (NASDAQ:PRENW – Get Free Report) is projected to issue its results before the market opens on Tuesday, August 18th. Analysts expect the company to announce earnings of ($0.84) per share and revenue of $49.85 million for the quarter.
Prenetics Global Trading Down 26.1%
NASDAQ PRENW opened at $0.01 on Tuesday. The business’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.02. Prenetics Global has a 12-month low of $0.01 and a 12-month high of $0.04.
About Prenetics Global
Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.
Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.
Featured Stories
- Five stocks we like better than Prenetics Global
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
